Clinical Trial Update: Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intravenous immunoglobulin (IVIg) for childhood-onset psychiatric disorders has completed. Conditions listed include autoimmun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Mental Disorders Diagnosed in Childhood
• Schizophrenia

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Autoimmune Diseases, Mental Disorders Diagnosed in Childhood | Phase 3 | Status: COMPLETED